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Clinopodium tomentosum (Kunth) Govaerts is an endemic species in Ecuador, where it is used as an anti-inflammatory plant to
treat respiratory and digestive affections. In this work, effects of a Clinopodium tomentosum ethanolic extract (CTEE), prepared
from aerial parts of the plant, were investigated on vascular endothelium functions. In particularly, angiogenesis activity was
evaluated, using primary cultures of porcine aortic endothelial cells (pAECs). Cells were cultured for 24 h in the presence of
CTEE different concentrations (10, 25, 50, and 100 μg/ml); no viability alterations were found in the 10-50μg/ml range, while a
slight, but significant, proliferative effect was observed at the highest dose. In addition, treatment with CTEE was able to rescue
LPS-induced injury in terms of cell viability. The CTEE ability to affect angiogenesis was evaluated by scratch test analysis and
by an in vitro capillary-like network assay. Treatment with 25-50 μg/ml of extract caused a significant increase in pAEC’s
migration and tube formation capabilities compared to untreated cells, as results from the increased master junctions’ number.
On the other hand, CTEE at 100μg/ml did not induce the same effects. Quantitative PCR data demonstrated that FLK-1 mRNA
expression significantly increased at a CTEE dose of 25 μg/ml. The CTEE phytochemical composition was assessed through
HPLC-DAD; rosmarinic acid among phenolic acids and hesperidin among flavonoids were found as major phenolic
components. Total phenolic content and total flavonoid content assays showed that flavonoids are the most abundant class of
polyphenols. The CTEE antioxidant activity was also showed by means of the DPPH and ORAC assays. Results indicate that
CTEE possesses an angiogenic capacity in a dose-dependent manner; this represents an initial step in elucidating the
mechanism of the therapeutic use of the plant.
1. Introduction
Medicinal plants are presently in demand, and their accep-
tance is increasing progressively. According to the most
recent WHO Report on Traditional and Complementary
Medicine (T&CM), several countries worldwide are develop-
ing guidelines aimed at a good harmonization of T&CM
therapies within their health care systems [1]. An optimal
exploitation of the potential contribution of traditional med-
icine to the health care system was indeed identified as a key
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strategic objective of the “WHO Traditional Medicine Strat-
egy: 2014-2023” [2]. In Ecuador, considered a country with
a huge biodiversity, an estimated 17,000 plant species have
so far been recorded, of whommore than 3,000 are medicinal
plants with promising potential, widely used for healing in
several cultures [3–5]. Of note, in Ecuador, current law pro-
motes implementation of indigenous medicine in health
services [1]. Despite that, most medicinal plants utilized in
traditional medicine are still scientifically untested; their use
is not monitored; information about effective dose, route of
administration, and potential adverse effects is limited and
identification of the safest, most effective and most rational
practices for their use is lacking [6].
The Lamiaceae family includes thousands of aromatic
plants growing in many regions of the world. Several of them
have been studied for their biological and medical applica-
tions [7]; more than 50 species of this family are used to treat
different affections in Ecuadorian folk medicine [8]. In
particular, the Clinopodium genus of Lamiaceae is widely
distributed in southern and southeastern Europe, Asia, and
the Americas [9, 10], whereby many species of the genus
are used as medicinal plants. Previous phytochemical studies
on plants belonging to the Clinopodium genus have revealed
the presence of several compounds, including flavonoids
[10], phenylpropanoids [11], diterpenes, and triterpenoid
saponins [12], as well as volatile and fatty oils, that exhibit
different biological activities [13–15]. Seven species of
Clinopodium are endemic in Ecuador, distributed in the
central region and used, albeit not exclusively, for their
medicinal properties. Clinopodium tomentosum (Kunth)
Govaerts, commonly known as “pumin”, is a subshrub with
small orange-yellow flowers that grows between 2000 and
4000m a.s.l. In traditional medicine, local people use aerial
parts of the plant to treat respiratory affections, inflamma-
tion, and gastrointestinal disorders [8]. Despite the tradi-
tional uses of the plant, at the best of our knowledge, only
the phytochemical composition of the essential oil [16] and
some phenolic compounds [17] have been reported. No
studies regarding its biological effects in vivo or in vitro have
been published.
Due to the putative anti-inflammatory effects of C.
tomentosum, and in view of the role of angiogenesis in
inflammatory response, its effects on the angiogenetic pro-
cess are worth investigating. Inflammation and angiogenesis
are indeed linked processes either in physiological or patho-
logical conditions such as wound healing, tumor growth, or
cardiovascular diseases [18–21]. In general, angiogenesis is
tightly controlled by a balance of pro- and anti-angiogenic
factors and mainly by vascular endothelial growth factor
(VEGF) [22–24]. On the other hand, VEGF interacts with
various cell surface receptors to mediate its cellular effects
and FLK-1 (VEGFR-2) is its main signaling receptor,
expressed solely by endothelial cells (ECs) [25]. Different
cellular types (endothelial cells, pericytes, fibroblasts, and
macrophages) and the surrounding extracellular matrix
interplay a fundamental role in this complex process. In
particular, ECs play a crucial role in the first step of
angiogenesis mediated by tip cell migration and stalk cell
proliferation [26].
It is also important to note that vascular endothelium, as
a whole, is the largest organ in the body, crucial for the regu-
lation and maintenance of the homeostasis of the whole
organism [27–29]. Due to scientific interest for the multiple
functions of ECs, an increasing number of publications are
available on the use of their primary cultures in biological
studies. Bernardini et al. [30] have isolated and characterized
a primary culture of porcine aortic endothelial cells (pAECs),
which have been already used as an in vitromodel to evaluate
different substances and plant extract effects on the endothe-
lial functions [31–34].
Thus, the present research was performed with the pur-
pose to evaluate the effects of an ethanolic extract of C.
tomentosum (CTEE) leaves on the viability and function of
vascular endothelium using pAECs. Additionally, CTEE
phytochemical and antioxidant activity profiles were investi-
gated to provide support for the possible activity mechanisms
of the extract.
2. Materials and Methods
2.1. Chemicals and Reagents.Human Endothelial Serum Free
Medium (hESFM), heat-inactivated fetal bovine serum
(FBS), antibiotic-antimycotic (100x solution), Dulbecco’s
phosphate buffered saline (DPBS), and phosphate buffered
saline (PBS) were purchased from Gibco Life Technologies
(Carlsbad CA, USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT); Folin-Ciocalteu’s phenol
reagent; 1,1-diphenyl-2-picrylhydrazyl (DPPH); 6-hydroxyl-
2,5,7,8-tetramethyl-chroman-2-carboxylic acid (Trolox); pure
standards of phenolic acids (4-hydroxybenzoic, gallic, caffeic,
chlorogenic, ferulic, p-coumaric, synapic, syringic, trans-cin-
namic, and rosmarinic acids); flavonoids (quercetin,
quercetin-3-O-glucoside, quercetin-3-O-rutinoside, querce-
tin-3-O-galactoside, kaempferol, kaempferol-3-O-rutinoside,
hesperetin, and hesperidin); and HPLC-grade solvents were
purchased from Sigma-Aldrich Italia (Milan, Italy). All stan-
dards (>99.5% purity in powder form) were prepared as stock
solutions at 1mg/ml in methanol and stored in the dark at
-18°C for less than three months.
2.2. Preparation of Plant Extract. Clinopodium tomentosum
(Kunth) Govaerts plants were collected, according to previ-
ous authorization of Ministry of the Environment (Nr. 003-
IC-DPACH-MAE-2018-F), in Riobamba, Ecuador, on May
2016. Plants were identified and certified by Escuela Superior
Politecnica de Chimborazo Herbarium, Riobamba, Ecuador,
and a voucher specimen was deposited (N. 702). Dried leaves
(300 g) were finely ground and extracted with 96% ethanol
for 48 h at room temperature. After filtration, the solvent
was evaporated using a rotary vacuum evaporator ( Flawil,
Switzerland) and a crude extract was obtained with a yield
of 5.35%. For experiments, the dry extract was dissolved in
ethanol. The stock solution (20mg/ml) was further used for
HPLC analysis or diluted in culture media and membrane
filtered by a 0.2μm Millipore filter (Darmstadt, Germany).
2.3. Cell Culture and Treatments. pAECs were isolated and
maintained as previously described [30]. For this study, three
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biological replicates (n = 3), namely, cells from three different
swine aortas, were employed. Briefly, cells were seeded and
routinely cultured in T25 tissue culture flasks (4 × 105 cells/-
flask) (Beckton-Dickinson, Franklin Lakes, NJ, USA). Suc-
cessive experiments were conducted in 96-well plates (cell
viability test), 24-well plates (wound healing migration
assay), and 8-slide chambers (tube formation assay) at con-
fluent cultures. Cells were cultured in hESFM, added with
5% FBS and 1x antibiotic-antimycotic solution in a 5% CO2
atmosphere at 38.5°C.
The dry extract was dissolved in ethanol (98%) to obtain
a stock solution (20mg/ml) and then in culture medium to
obtain desired concentrations of CTEE and ethanol 1% for
cell exposure. Ethanol (1%) was used as control vehicle.
2.4. Cell Viability. To determine if CTEE affects cell viability,
an MTT assay was used. In particular, pAECs were seeded in
96-well culture plates at a density of 3 × 103 cells/well,
incubated overnight; then, media were replaced with hESFM
containing 5% FBS and increasing CTEE doses (10, 25, 50,
and 100μg/ml). After 24 h of incubation, MTT solution
(5mg/ml in PBS) was added to a final concentration of
0.5mg/ml. After 2 h of additional incubation, 0.1ml/well of
MTT solubilization solution was added. Formazan Abs was
determined at 570nm, using Infinite® F50/Robotic absor-
bance microplate readers from TECAN Life Sciences
(Männedorf, Switzerland).
The effect of CTEE on LPS-induced injury was also stud-
ied; pAECs were seeded in 96-well culture plates at a density
of 12 × 103 cells/well and incubated for 24 h, then exposed to
different concentrations of CTEE (10, 25, 50, and 100μg/ml)
in the presence of LPS (25μg/ml). After another 24 h of incu-
bation, cell viability was evaluated by the MTT assay, as pre-
viously described.
2.5. Cell Cycle. When pAECs had reached 80% of confluence
in a T25 flask, medium was replaced with hESFM containing
5% FBS and increasing CTEE doses (10, 25, 50, and
100μg/ml). After 24 h, pAECs were harvested, washed once
in 10ml of PBS, and 1ml/106 cells of 70% ice-cold ethanol
was added drop wise with continuous vortexing. The single
cell suspension was fixed at 4°C for 24h. Then, cells were
washed with 10ml of PBS and cellular precipitate was incu-
bated with 1mL/106 cells of staining solution containing
50μg/ml of propidium iodide (PI) and 100μg/ml of RNa-
seA/T1 in PBS, for 30min in the dark at room temperature.
Cell distribution in cell cycle phases was analyzed by MACS-
Quant® Analyzer10 and Flowlogic software (Miltenyi Biotec,
Bergisch Gladbach, Germany). 2 × 105 cells were examined
for each sample. The Dean-Jett-Fox Univariate Model was
used for this analysis [35].
2.6. In Vitro Wound Healing Migration Assay. To investigate
CTEE’s effect on pAEC migration capacity, a wound healing
assay was performed as previously reported [33]. Briefly,
pAECs (4 × 104 cells/well) were seeded in 24-well culture
plates and incubated at 38.5°C and 5% CO2 until confluence.
Then, cells were scratched with a 200μL pipette tip along the
well diameter, medium was aspirated, and the well washed
twice with PBS to remove all detached cells. Cells were then
incubated in hESFM with 1% FBS and increasing CTEE
doses (10, 25, 50, and 100μg/ml). These culture conditions
minimized pAEC proliferation. Three linear measurements
of the distance between wound margins were taken for each
sample immediately and 18 h after scratching. Average mea-
surement value was an estimation of the damaged area.
Images were acquired using a Nikon (Yokohama, Japan)
epifluorescence phase-contrast microscope equipped with a
digital camera.
2.7. In Vitro Capillary-Like Tube Formation Assay. The
experiments were carried out using 8 -slide chambers (BD
Falcon Bedford, MA, USA) coated with undiluted Geltrex™
LDEV-Free Reduced Growth Factor Basement Membrane
Matrix (Thermo Fisher, Waltham, MA, USA). Extracellular
matrix coating was carried out 1 h before the cell seeding in
a humidified incubator, at 38.5°C, 5% CO2; then, pAECs
(8 × 104 cells/well) were seeded with increasing CTEE doses
(10, 25, 50, and 100μg/ml) and incubated for 18 h. At the
end of the experimental time, images were acquired using a
digital camera installed on a Nikon phase contrast micro-
scope and analyzed by Image J 64 open software (National
Institutes of Health, Bethesda, USA).
2.8. Quantitative Real-Time PCR for VEGF and FLK-1.
pAECs were seeded in a 24-well plate (4 × 104 cells/well),
incubated until confluence and then exposed to different
CTEE concentrations (10, 25, 50, and 100μg/ml). After
24 h, cells were harvested and lysed using 1ml Trizol reagent.
A volume of 200μL of chloroform was then added to the
suspension and mixed well. After incubation at room tem-
perature (10min), samples were centrifuged (12000 × g for
10min) and the aqueous phase was recovered. An equal vol-
ume of absolute ethanol (99%) was added, and the resulting
solution was applied to a NucleoSpin RNA Column. RNA
was then purified according to the manufacturer’s instruc-
tions. After spectrophotometric quantification, total RNA
(250ng) was reverse-transcripted to cDNA using the iScript
cDNA Synthesis Kit in a final volume of 20μL.
Swine primers were designed using Beacon Designer 2.07
(Premier Biosoft International, Palo Alto, CA, USA). Primer
sequences, expected PCR product lengths, and accession
numbers in the NCBI database are shown in Table 1.
To evaluate gene expression profiles, quantitative real-
time PCR (qPCR) was performed in CFX96 thermal cycler
(Bio-Rad) using a multiplex real-time reaction (Taq-Man
probes) for reference genes (GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; HPRT, hypoxanthine guanine
phosphoribosyl transferase; and β-actin) and using SYBR
green detection for target genes (VEGF and FLK-1, respec-
tively). All amplification reactions were performed in 20μL
and analyzed in duplicates (10μL/well). Multiplex PCR and
SYBR green reactions were carried out as previously
described [34]. The specificity of the amplified PCR products
was confirmed by agarose gel electrophoresis and melting
curve analysis. The relative expressions of the studied genes
were normalized based on the geometric mean of the three
reference genes. The relative mRNA expression of tested
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genes was evaluated as a fold of increase using the 2-ΔΔCT
method [39] referred to pAECs cultured under standard
conditions (control).
2.9. Total Phenol Content and Total Flavonoid Content. Total
phenol content (TPC) of the extract was determined using
the Folin–Ciocalteu method [40], with modifications [34].
Results, determined from regression equation of the calibra-
tion curve, were expressed as mg gallic acid equivalents
(GAE)/g extract.
Total flavonoid content (TFC) was determined according
to Zhishen et al. [41] with some modifications [34]. Results
were expressed as mmol rutin equivalents (RE)/g extract.
2.10. HPLC Determination of Phenolic Acids and Flavonoids.
20μL of ethanolic extract were injected into the HPLC sys-
tem (Jasco, Tokyo, Japan; PU-4180 pump, MD-4015 PDA
detector, AS-4050 autosampler). The stationary phase was
an Agilent (Santa Clara, CA, USA) Zorbax Eclipse Plus C18
reversed-phase column (100 × 3mm I.D., 3.5μm). The chro-
matographic method for the analysis of phenolic acids was
adapted from Mattila and Kumpulainen [42] as detailed in
Tubon et al. [34]. Gradient elution was carried out with a
mixture of acidic phosphate buffer (50mM, pH2.5) and ace-
tonitrile flowing at 0.7ml/min. The signals at 254, 280, and
329 nm were used for analyte quantitation. The recovery
values of phenolic acids in spiked samples ranged from
78.8 to 92.2% (RSD < 9:8%, n = 6). The chromatographic
method for the analysis of flavonoids was adapted from
Wojdyło et al. [43], as previously reported [34]. Gradient
elution was carried out with a mixture of 4.5% formic acid
and acetonitrile. Runs were monitored at the following
wavelengths: flavan-3-ols and flavanones at 280 nm and
flavonol glycosides at 360nm. PDA spectra were measured
over the wavelength range of 200−600nm in steps of
2 nm. Retention times and spectra were compared with
those of pure standards. Calibration curves were con-
structed for all standards at concentrations ranging from
1.0 to 100.0μg/ml (r2 ≥ 0:9998). Results are expressed as
mg/g extract.
2.11. Antioxidant Activity Assays. Antioxidant activity (AA)
of the extract was measured by the ORAC and DPPH assays.
Table 1: Primers used for quantitative real-time polymerase chain reaction analysis.
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Figure 1: Effect of CTEE on pAEC cell viability. Cell viability was
measured by the MTT assay after treatment with different
concentrations of CTEE. Data represent mean ± S:D: (n = 3).
Different letters above the bars indicate significant differences
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Figure 2: Effect of CTEE on LPS-induced pAEC damage. Cell
viability was measured by the MTT assay after treatment with LPS
(25 μg/ml) and different concentrations of CTEE. Data represent
mean ± S:D: (n = 3). Different letters above the bars indicate
significant differences (p < 0:05 ANOVA post hoc Tukey’s test).
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The ORAC assay was performed in an automated plate
reader (Victor 3, Perkin Elmer, Shelton, CT, USA) with 96-
well plates, according to Ou et al. [44] with some modifica-
tions [45]. The final ORAC values were calculated by using
a regression equation between the Trolox concentration
and the net area under the FL decay curve and were
expressed as mmol Trolox equivalents (TE)/g extract.
The DPPH assay was done according to the method of
Brand-Williams et al. [46] with some modifications. Results
were determined from the regression equation of the calibra-
tion curve of Trolox in the 25-500μM range and expressed as
mmol TE/g extract.
2.12. Statistical Analysis. The experiments were performed
using three biological replicates (n = 3). Each treatment was
replicated three or eight (viability test) times (technical repli-
cates). Data were analysed by a one-way analysis of variance
(ANOVA) followed by the post hoc Tukey comparison test.
Differences of at least p < 0:05 were considered significant.
Statistical analysis was carried out using GraphPad (San
Diego, CA, USA) Prism 7 software.
3. Results and Discussion
3.1. Effect of CTEE on pAEC Viability, LPS-Induced
Cytotoxicity, and Cell Cycle. MTT tests were carried out to
evaluate if CTEE affects pAEC viability in control conditions
or during an LPS-induced damage.
After 24h of treatment, cell viability was not affected by
CTEE in the 10-50μg/ml concentration range (Figure 1),
while a slight, but significant, proliferative effect was
observed at the highest concentration (100μg/ml). These
results are in accordance with those obtained by other
authors using other species of the same genus both in vitro
and in vivo [10, 47, 48].
Previous studies have demonstrated that primary cul-
tures of pAECs could be used as a suitable in vitro model to
assess not only cytotoxicity by xenobiotics, but also their
effects on cell physiology, such as angiogenic and anti-
inflammatory activities [31–34]. Since Clinopodium tomento-
sum is used as an anti-inflammatory agent in traditional
medicine, the CTEE effect against LPS-induced injury was
also investigated on pAECs by the MTT assay. LPS produced
an evident cytotoxicity on pAECs, reducing their viability by
about 25% (Figure 2). After 24 h of treatment with CTEE, no
inflammatory damage by LPS was observed, with maximum
protective effect at 100μg/ml (Figure 2).
Similar results for Clinopodium vulgare were reported by
Burk and colleagues [9], in which the aqueous extract
reduced the LPS inflammatory effect on 264.7 murine macro-
phages by suppressing the activation of the NF-κB pathway.
Flow cytometry analysis showed that CTEE treatment
affects pAEC cell cycle. As represented in Figure 3, CTEE
induced a decrease in the number of cells in the G0/G1 phase
and an increase in the number of cells in S and G2/M phases.
Sub-G0/G1 population was essentially absent in all DNA
content frequency histograms, which means that CTEE
exerted a proliferative effect and did not induce either apo-
ptosis or necrosis, at least in the tested dose range. These data
are in agreement with the above described viability data.
3.2. Effect of CTEE on Angiogenic Activity. Considering the
pivotal role of ECs in the maintenance of vascular integrity,
the effect of CTEE on pAEC functional angiogenic activity
was evaluated.
pAEC migration capacity in a wounded edge was tested
by the scratch test. Treatment with 25 and 50μg/ml CTEE
significantly enhanced pAEC migration capability compared
to the control; in fact, the wound area was significantly
reduced. On the other hand, CTEE at 100μg/ml shared a
migration capacity comparable to the control (Figure 4).
Then, pAEC ability to form an organized capillary network
was evaluated by in vitro capillary-like tube formation assay;

































Figure 3: Dean-Jett-Fox Univariate cell cycle analysis by flow cytometry. Fluorescence of the PI-stained pAECs was measured using
MACSQuant® Analyzer 10 and analyzed by Flowlogic software (Miltenyi Biotec, Bergisch Gladbach, Germany). 2 × 105 cells were
examined for each sample (n = 3), and the experiment was repeated twice. (a) Representative DNA content frequency histograms. (b) Cell
cycle distribution for pAECs treated with various concentrations of CTEE (10, 25, 50, and 100 μg/ml) for 24 h in a grouped histograms
graph. (∗p < 0:0001; Δp < 0:001; □p < 0:01).
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significant increase in the number of master junctions com-
pared with the control group (Figure 5). Similarly to what
was seen in the migration test, pAECs treated with CTEE at
100μg/ml are not different from the control (Figure 5). These
results allow to conclude that 25 and 50μg/ml CTEE treat-
ment can improve pAEC angiogenic capability.
3.3. Effect of CTEE on VEGF and FLK-1 Expression. Quanti-
tative PCR data demonstrated that CTEE significantly
increases FLK-1 expression at a dose of 25μg/ml. When
pAECs were treated with higher CTEE concentrations,
FLK-1 expression progressively returned to basal levels. On
the contrary, no significant statistical difference in VEGF
mRNA expression was observed among different CTEE
doses (Figure 6).
Overall, these data demonstrate that CTEE at 25 and
50μg/ml stimulated angiogenesis, but this did not occur at
a higher dose (100μg/ml). In this in vitro model, the proan-
giogenic cue could be represented by a significant increase
in the function of FLK-1, the main VEGF receptor.
No data regarding the angiogenic activity of C. tomento-
sum are reported in literature. However, Zeng et al. [11]
showed that phenolic compounds of Clinopodium chinensis
exerted a strong protective effect in vascular endothelial cell
injury. Moreover, a protective effect against doxorubicin-
induced cardiotoxicity was demonstrated both in vitro and
in vivo by the flavonoid fraction of this species of Clinopo-
dium chinensis [14]. Likewise, Zhang et al. [49], following
the previously cited studies, demonstrated that pretreatment






















Figure 5: CTEE effect on pAEC tube formation capability. pAECs were cultured on an extracellular matrix for 18 h with different
concentrations of CTEE (25, 50, and 100μg/ml). (a) Representative microscopic phase-contrast pictures showing capillary network in
different treatment groups compared with control. Scale bar, 100μm. (b) Number of master junctions in pAEC network. Data represent





















Figure 4: Effect of CTEE on pAEC migration capability. Cells were scratch wounded and then treated with CTEE at different concentrations
(25, 50, and 100 μg/ml). Photographs were recorded at 18 h after scratching. (a) Representative microscopic phase-contrast pictures showing
the size of the scratch wound in the 25 μg/ml CTEE-treated group compared with control. Scale bar, 100μm. (b) Damaged area (percentage of
the original scratch) as a function of different CTEE concentrations. Data represent mean ± S:D: (n = 3). Different letters above the bars
indicate significant differences (p < 0:05 ANOVA post hoc Tukey’s test).
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chinensis protected against ischemic myocardial injury both
in vitro and in vivo.
3.4. Phytochemical Analysis and In Vitro Antioxidant
Capacity of CTEE. Determination of TPC and TFC revealed
that CTEE contained high amounts of polyphenols
(140:15 ± 0:12mg GAE/g extract), and a relevant percentage
of polyphenolic structures was represented by flavonoids
(Table 2). According to HPLC-DAD analyses, rosmarinic
acid was the main phenolic acid detected in the extracts,
followed by chlorogenic acid and cinnamic acid, respectively.
Within the flavonoid class, the flavanone glycoside hesperi-
din turned the most abundant compound, followed by
hesperetin, kaempferol, and rutin, respectively. Moreover,
CTEE showed a good antioxidant activity, as a results from
both DPPH (3.72mmol TE/g) and ORAC (4.14mmol
TE/g) assays, as shown in Table 2.
TPC in CTEE resulted very similar to that reported for a
similar ethanolic extract of Salvia sagittata, a species belong-
ing to the same family [34], and was of the same order of
magnitude as that reported in a Thymus vulgaris methanolic
extract [50].
Based on the phytochemical composition and the major
compounds found in CTEE, it is not possible to attribute to
a single molecule the effects it exerts on pAECs. Different
studies confirm the protective and anti-inflammatory effect
of rosmarinic acid [51–53], as well as the protective role of
hesperidin in cardiovascular diseases and its angiogenic
effects in diabetic foot ulcer [54–56]. Even though the role
of phenolic acids on cell migration and angiogenesis has
not been completely clarified and appears somehow contro-
versial [57], an angiogenic effect has been reported for some
members of the polyphenol family [58]. An increase in endo-
thelial cell migration, accompanied by cytoskeletal reforma-
tion, was observed in an in vitro wound healing assay by a
phenolic acid extract enriched in chlorogenic acid [59]. Thus,
it is possible to hypothesize that some of the main compo-
nents of CTEE, belonging to the polyphenol family, could
be, at least in part, responsible for the observed angiogenic
effect, even though an overall action of the whole phytocom-
plex cannot be excluded, given the multicomponent nature of
the tested extract.
To summarize, the present study demonstrates the angio-
genic effect of CTEE on pAECs but only at the intermediate
doses utilized, probably mediated by the VEGF-FLK-1 path-
way. However, the highest CTEE dose (100μg/ml) increased
EC viability (and metabolic activity), not only in basal condi-
tions but also in the presence of a proinflammatory stimulus.
We can speculate that 100μg/ml CTEE induced stalk cell
proliferation but not tip cell migration as confirmed by the
absence of capillary formation capacity.
This is the first study providing a scientific rationale for














































Figure 6: CTEE effect on VEGF and FLK-1 gene expressions. Relative expression (RE) was calculated as a fold of change with respect to the
control cells; error bars represent the range of relative gene expression (n = 3). Different letters above the bars indicate significant differences
(p < 0:05 ANOVA post hoc Tukey’s test).
Table 2: AA, TPC, TFC, phenolic acids, and flavonoid content in
CTEE. Data are the mean ± S:E: of three technical determinations.
Assays or compounds∗
Concentration∗∗ referred to
Ethanolic extract Plant dry weight
AA
ORAC 4:14 ± 0:24 0:22 ± 0:04
DPPH 3:72 ± 0:11 0:20 ± 0:01
TPC 140:15 ± 0:12 7:50 ± 0:4
TFC 97:38 ± 0:62 5:21 ± 0:2
Phenolic acids
RA 37:03 ± 0:58 1:98 ± 0:1
CHA 1:66 ± 0:35 0:08 ± 0:01
CA 0:65 ± 0:03 0:04 ± 0:01
Flavonoids
HESD 16:76 ± 0:89 0:90 ± 0:03
HEST 4:14 ± 0:14 0:22 ± 0:01
KMP 3:97 ± 0:25 0:21 ± 0:02
RUT 1:95 ± 0:06 0:10 ± 0:01
∗RA= rosmarinic acid; CHA= chlorogenic acid; CA = cinnamic acid;
HESD = hesperidin; HEST = hesperetin, KMP = kaempferol; RUT = rutin.
∗∗units: ORAC and DPPH, mmol TE/g; TPC, mg GAE/g; TFC, mmol RE/g.
phenolic acids and flavonoids, mg/g.
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Nevertheless, further investigations should be performed to
elucidate the pathways by which the plant extract exerts its
effects on endothelial cells.
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